Heart Test Laboratories Inc. Common Stock
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $0.76
- Today's High:
- $0.8
- Open Price:
- $0.8
- 52W Low:
- $0.601
- 52W High:
- $3.95
- Prev. Close:
- $0.78
- Volume:
- 12996
Company Statistics
- Market Cap.:
- $7.25 million
- Book Value:
- 0.023
- Revenue TTM:
- $5150
- Operating Margin TTM:
- -118698.33%
- Gross Profit TTM:
- $2354
- Profit Margin:
- 0%
- Return on Assets TTM:
- -142.12%
- Return on Equity TTM:
- 0%
Company Profile
Heart Test Laboratories Inc. Common Stock had its IPO on 2022-06-15 under the ticker symbol HSCS.
The company operates in the Healthcare sector and Medical Devices industry. Heart Test Laboratories Inc. Common Stock has a staff strength of 12 employees.
Stock update
Shares of Heart Test Laboratories Inc. Common Stock opened at $0.8 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.76 - $0.8, and closed at $0.8.
This is a +2.55% increase from the previous day's closing price.
A total volume of 12,996 shares were traded at the close of the day’s session.
In the last one week, shares of Heart Test Laboratories Inc. Common Stock have increased by +14.27%.
Heart Test Laboratories Inc. Common Stock's Key Ratios
Heart Test Laboratories Inc. Common Stock has a market cap of $7.25 million, indicating a price to book ratio of 3.6653 and a price to sales ratio of 813.0191.
In the last 12-months Heart Test Laboratories Inc. Common Stock’s revenue was $5150 with a gross profit of $2354 and an EBITDA of $-6086049. The EBITDA ratio measures Heart Test Laboratories Inc. Common Stock's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Heart Test Laboratories Inc. Common Stock’s operating margin was -118698.33% while its return on assets stood at -142.12% with a return of equity of 0%.
In Q1.3333333333333, Heart Test Laboratories Inc. Common Stock’s quarterly earnings growth was a positive 0% while revenue growth was a negative 100%.
Heart Test Laboratories Inc. Common Stock’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at $-0.86 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Heart Test Laboratories Inc. Common Stock’s profitability.
Heart Test Laboratories Inc. Common Stock stock is trading at a EV to sales ratio of 743.4582 and a EV to EBITDA ratio of -1.3798. Its price to sales ratio in the trailing 12-months stood at 813.0191.
Heart Test Laboratories Inc. Common Stock stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $3.29 million
- Total Liabilities
- $1.83 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $7592
- Dividend Payout Ratio
- 0%
Heart Test Laboratories Inc. Common Stock ended 2024 with $3.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $3.29 million while shareholder equity stood at $230557.00.
Heart Test Laboratories Inc. Common Stock ended 2024 with $0 in deferred long-term liabilities, $1.83 million in other current liabilities, 10118.00 in common stock, $-60757198.00 in retained earnings and $0 in goodwill. Its cash balance stood at $1.66 million and cash and short-term investments were $1.66 million. The company’s total short-term debt was $529,535 while long-term debt stood at $500000.00.
Heart Test Laboratories Inc. Common Stock’s total current assets stands at $2.70 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $319381.00 compared to accounts payable of $631369.00 and inventory worth $676359.00.
In 2024, Heart Test Laboratories Inc. Common Stock's operating cash flow was $0 while its capital expenditure stood at $7592.
Comparatively, Heart Test Laboratories Inc. Common Stock paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $0.8
- 52-Week High
- $3.95
- 52-Week Low
- $0.601
- Analyst Target Price
- $3.57
Heart Test Laboratories Inc. Common Stock stock is currently trading at $0.8 per share. It touched a 52-week high of $3.95 and a 52-week low of $3.95. Analysts tracking the stock have a 12-month average target price of $3.57.
Its 50-day moving average was $0.84 and 200-day moving average was $1.08 The short ratio stood at 0.26 indicating a short percent outstanding of 0%.
Around 2282.9% of the company’s stock are held by insiders while 529.6% are held by institutions.
Frequently Asked Questions About Heart Test Laboratories Inc. Common Stock
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor’s offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.